A new medical imager for detecting and guiding the biopsy of suspicious breast cancer lesions is capable of spotting tumors that are half the size of the smallest ones detected by standard imaging systems, according to a new study.
The results of initial testing of the PEM/PET system, designed and constructed by scientists at the Department of Energy’s Thomas Jefferson National Accelerator Facility, West Virginia University School of Medicine and the University of Maryland School of Medicine will be published in the journal
Physics in Medicine and Biology on Feb. 7.
“This is the most-important and most-difficult imager we’ve developed so far,” Stan Majewski, Jefferson Lab Radiation Detector and Medical Imaging Group leader said. “It is another example of nuclear physics detector technology that we have put a lot of time and effort into adapting for the common good.”
Testing of the new imager was led by Ray Raylman, a professor of radiology and vice chair of Radiology Research at WVU and lead author on the study. Raylman’s team imaged various radioactive sources to test the resolution of the system.
“We had good performance characteristics, with image resolution below two millimeters. In regular PET, the image resolution is over five millimeters, so we're quite a bit better than that,” Raylman said. In addition, the initial tests revealed that the PEM/PET system can complete an image and biopsy in about the same amount of time as a traditional biopsy.
“The ability of the device to do biopsy is probably one of its most unique characteristics. There are other breast imagers, but none that are built specifically to do biopsy as well as imaging,” Raylman said.
The system features components designed for imaging the unique contours of the breast. Known as positron emission mammography (PEM), this imaging capability enables users to attain high-resolution, three-dimensional PET images of the breast. The PEM/PET system images the breast with a movable array of two pairs of two flat detection heads.
If a suspected lesion is found, a single pair of heads is then used to guide a needle biopsy of the lesion; the biopsy is performed with a person-controlled robot arm. Raylman is the author of the concept and has a patent on this idea. The system is especially useful in imaging tumors in women who have indeterminate mammograms because of dense or fibroglandular breasts.
The Jefferson Lab Radiation Detector and Medical Imaging Group, with a group member now affiliated with the University of Maryland School of Medicine, developed the detector heads with the on-board electronics, the data acquisition readout and the image reconstruction software. The imaging device’s gantry and the motion-control software was developed by West Virginia University researchers.
Source: Thomas Jefferson National Accelerator Facility
Related stories:
Researchers locate and image prostate cancer as it spreads to lymph nodes
Using an engineered common cold virus, UCLA researchers delivered a genetic payload to prostate cancer cells that allowed them, using Positron Emission Tomography (PET), to locate the diseased cells as they spread to the lymph nodes, the first place prostate cancer goes before invading other organs.
Mammography facility characteristics associated with accuracy of screening
Some characteristics of mammography facilities are associated with the accuracy of interpretation of screening mammograms, according to a study published online June 10 in the
Journal of the National Cancer Institute.
Adding ultrasound to mammography may improve breast cancer detection in high-risk women
The addition of an ultrasound examination to mammography for women at high-risk of breast cancer resulted in a higher rate of cancer detection, but also increased the number of false-positive results, according to a study in the May 14 issue of JAMA.
Adding ultrasound screening to mammography brings benefits, risks
Adding a screening ultrasound examination to routine mammography reveals more breast cancers than mammography alone, according to results of a major new clinical trial. The trial, however, also found that adding an ultrasound exam also increases the rate of false positive findings and unnecessary biopsies.
6-month follow-up diagnostic mammograms recommended for women with probably benign lesions
Radiologists can, with confidence, recommend a six-month follow-up diagnostic mammogram rather than an immediate biopsy for patients with “probably benign” breast lesions, a new study emphasizes.
Study finds patients with complex fibroadenomas can avoid surgery
Complex fibroadenomas have a low incidence of malignancy, so women with this condition can be more conservatively treated and avoid surgical biopsy, according to a new study by a team of researchers from the Hadassah-Hebrew University Medical Center in Jerusalem.
Digital mammography superior to film mammography in some cases
For some women, digital mammography may be a better screening option than film mammography, according to newly published results from the Digital Mammographic Imaging Screening Trial (DMIST). The results appear in the February issue of
Radiology. The study found that digital mammography performed better than film mammography for pre- and perimenopausal women under age 50 with dense breasts.
Breast MRI spots other cancers, may alter treatment plan
In about 20 percent of women with breast cancer who plan to undergo a lumpectomy, breast magnetic resonance imaging reveals important diagnostic information that alters their treatment plan, University of Florida surgeons reported today (Dec. 5).